ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OM vs STXS // PIOTROSKI F-SCORE QUALITY

Outset Medical Inc. (NASDAQ) VS. Stereotaxis Inc. (NYSE) • 15-METRIC TALLY: OM 4 — STXS 3
▲ PIOTROSKI F-SCORE QUALITY LEADER: OM
piotroski-score
6/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OM VS. STXS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OM STXS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 39.10% 52.70% -13.60 STXS /gross-margins <GO>
Return on Invested Capital (ROIC) -28.00% -35.00% +7.00 OM /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -15.01% — TIE /fcf-yield <GO>
Operating Margin -55.80% -60.00% +4.20 OM /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 5.10% 20.30% -15.20 STXS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 6/9 5/9 +1.00 OM /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 55.8 30.8 +25.00 OM /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $78.8M $91.2M -$12.4M STXS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OM REV STXS REV OM GROSS % STXS GROSS % OM FCF STXS FCF
FY 2025 $119.5M $32.4M 39.1% 52.7% -$47.1M -$13.7M
FY 2024 $113.7M $26.9M 33.9% 54.2% -$117.2M -$8.5M
FY 2023 $130.4M $26.8M — — -$131.4M -$9.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OM // BETA —
STXS // BETA —